Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 58 of 58 entries
View as:

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT05593666 Org: User:
Start: 12/27/22 End: 01/02/25 Due: 01/02/26

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Phase: N/A Priority: Normal
NCT ID: NCT01067443 Org: User:
Start: 03/31/10 End: 06/30/11 Due: 06/30/12

Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨

Phase: N/A Priority: Normal
NCT ID: NCT02687971 Org: User:
Start: 12/31/16 End: 09/10/19 Due: 09/10/20

Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05256017 Org: User:
Start: 12/30/21 End: 08/03/23 Due: 08/03/24

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT01122771 Org: User:
Start: 05/31/10 End: 03/31/14 Due: 03/31/15

Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03836833 Org: User:
Start: 06/04/19 End: 12/31/19 Due: 12/31/20

Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT03453177 Org: User:
Start: 03/15/18 End: 05/24/19 Due: 05/24/20

A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study

Phase: N/A Priority: Normal
NCT ID: NCT03602300 Org: User:
Start: 06/05/18 End: 08/17/18 Due: 08/17/19